SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-15-009330
Filing Date
2015-11-16
Accepted
2015-11-16 17:01:04
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1502643_10q.htm 10-Q 246589
2 EXHIBIT 31.1 t1502643_ex31-1.htm EX-31.1 8849
3 EXHIBIT 32.1 t1502643_ex32-1.htm EX-32.1 5001
  Complete submission text file 0001571049-15-009330.txt   2724176

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE mrna-20150930.xml EX-101.INS 525415
5 XBRL SCHEMA FILE mrna-20150930.xsd EX-101.SCH 36603
6 XBRL CALCULATION FILE mrna-20150930_cal.xml EX-101.CAL 29850
7 XBRL DEFINITION FILE mrna-20150930_def.xml EX-101.DEF 142189
8 XBRL LABEL FILE mrna-20150930_lab.xml EX-101.LAB 302899
9 XBRL PRESENTATION FILE mrna-20150930_pre.xml EX-101.PRE 214000
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 151236007
SIC: 2834 Pharmaceutical Preparations